1Takase B,Uehata A,Akima T,et al.Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease[J].Am J Cardiol,1998,82(12):1535-1539,A7-A8.
2Kuvin JT,Patel AR,Sline KA,et al.Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease[J].J Am Coll Cardiol,2001,38(7):1843-1849.
3Gokce N,Keaney JF Jr,Hunter LM,et al.Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function:p prospective study[J].Circulation,2002,105(13):1567-1572.
4Heitzer T,Ollmann I,Koke K,et al.Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease[J].Circulation,2003,108(5):536-541.
5Coretti MC,Anderson TJ,Benjamin EJ,et al.Guidelines for the ultrasound assessment of endothelial-dependent-nediated vasodilation of the brachial artery:a report of the international brachial artery reactivity take force[J].J Am Coll Cardiol,2002,39(2):257-265.
6Leclerc JR.Platelet glycoprotein Ⅱb/Ⅲa antagonists lessons learned from clinical trials and futute directions[J].Crit Care Med,2002,30(5 Suppl):S332-S340.
